(Phys.org)—Tasmanian devils had low immune gene diversity for hundreds, and possibly thousands, of years before the emergence of Devil Facial Tumour Disease, researchers at the University of Sydney and University of Adelaide ...
Plants & Animals
Dec 5, 2012
0
0
A controversial study that linked genetically modified corn to cancer in lab rats is a "scientific non-event," six French scientific academies said on Friday.
Biotechnology
Oct 19, 2012
24
0
Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists ...
Bio & Medicine
Sep 13, 2012
0
0
(Phys.org) -- The degree of genetic difference to a tumor is not a factor in Tasmanian devils contracting the facial tumor disease, according to research led by the University of Sydney.
Plants & Animals
Jun 7, 2012
5
0
Two independent groups of researchers have identified a hormone that is responsible for keeping the growth and development of insects on track. The results, which are reported in the journal Science, suggest that Dilp8 provides ...
Cell & Microbiology
May 4, 2012
0
0
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells.
Biochemistry
Mar 26, 2012
0
0
A hardy type of bacteria recently discovered in the permafrost of Siberia could help slow down the ageing process, Russian scientists claimed on Tuesday.
Biochemistry
Jan 17, 2012
4
0
(PhysOrg.com) -- New active substances can be produced quickly and efficiently with the help of reaction cascades. Once set in motion, these processes lead to the desired end product via a series of intermediate steps which ...
Biochemistry
Dec 26, 2011
0
0
A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune system works. The drug, delivered in this way, reduced ...
Biotechnology
Sep 12, 2011
0
0
A bacterial strain that specifically targets tumours could soon be used as a vehicle to deliver drugs in frontline cancer therapy. The strain is expected to be tested in cancer patients in 2013 says a scientist at the Society ...
Cell & Microbiology
Sep 5, 2011
7
0
